Entrada Therapeutics Inc (TRDA)
17.60
+0.32
(+1.85%)
USD |
NASDAQ |
Dec 20, 16:00
17.60
0.00 (0.00%)
After-Hours: 20:00
Entrada Therapeutics Market Cap: 658.59M for Dec. 20, 2024
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Catalyst Pharmaceuticals Inc | 2.537B |
| Vertex Pharmaceuticals Inc | 102.31B |
| Sarepta Therapeutics Inc | 11.36B |
| Regenxbio Inc | 378.03M |
| Edgewise Therapeutics Inc | 2.911B |
Market Cap Related Metrics
| PE Ratio | 11.07 |
| PS Ratio | 2.950 |
| Price to Book Value | 1.559 |
| Price | 17.60 |
| Earnings Yield | 9.03% |
| Operating PE Ratio | 10.99 |
| Normalized PE Ratio | 11.07 |